Titlebook: Management of the Patient at High Risk for Breast Cancer; Nora M. Hansen Book 2013 Springer Science+Business Media New York 2013 BRCA gene

MEDAL

書目名稱Management of the Patient at High Risk for Breast Cancer影響因子(影響力)




書目名稱Management of the Patient at High Risk for Breast Cancer影響因子(影響力)學(xué)科排名




書目名稱Management of the Patient at High Risk for Breast Cancer網(wǎng)絡(luò)公開度




書目名稱Management of the Patient at High Risk for Breast Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Management of the Patient at High Risk for Breast Cancer被引頻次




書目名稱Management of the Patient at High Risk for Breast Cancer被引頻次學(xué)科排名




書目名稱Management of the Patient at High Risk for Breast Cancer年度引用




書目名稱Management of the Patient at High Risk for Breast Cancer年度引用學(xué)科排名




書目名稱Management of the Patient at High Risk for Breast Cancer讀者反饋




書目名稱Management of the Patient at High Risk for Breast Cancer讀者反饋學(xué)科排名

DIKE

Scott M. Weissman M.S., C.G.C.phic information systems (GIS), global positioning system (GPS), and computing. As a result of these improvements, forest landscape ecologists and forest managers now have access to increasingly comprehensive and accurate georeferenced information that is frequently updated. However, the knowledge o

NAG

Lee P. Shulman M.D.sses and patterns and the factors that control them or that they control. For decades, landscape metrics have been used to measure and abstract landscape patterns. Since the emergence of FRAGSTATS in 1993, the measures and methods incorporated in this software have become widely used and are now a .

集聚成團(tuán)

Ashley N. Hardy M.D.,Elizabeth Tarasewicz B.S.,Jacqueline S. Jeruss M.D., Ph.D.sses and patterns and the factors that control them or that they control. For decades, landscape metrics have been used to measure and abstract landscape patterns. Since the emergence of FRAGSTATS in 1993, the measures and methods incorporated in this software have become widely used and are now a .

Germinate

neuron

證實(shí)

Erin Neuschler M.D.,Paula Grabler M.D.hway interactions. However, it can also assist in the development of innovative therapeutic strategies by uncovering novel drug targets used to combat diseases like cancer. To expedite the discovery of novel synthetic lethal interactions in humans, cross-species candidate gene approaches rely on the

electrolyte

Asymptomatic

聯(lián)想